Peron, J., Boige, V., Mariani, P., Eveno, C., Smith, D. M., Gladieff, L., Raimbourg, J., Pirro, N., Edeline, J., Viala, M., Brigand, C., Vicier, C., Tomasini, P., Tosi, D., Calattini, S., Bin, S., Subtil, F., You, B., Kepenekian, V. (2025). IMMUNORARE
            <sup>5</sup>
            : A national platform of 5 academic phase II trials coordinated by Lyon University Hospital to assess the safety and the efficacy of the immunotherapy with domvanalimab + zimberelimab combination in patients with advanced rare cancers—The Peritoneal Mesotheliomas Cohort.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps4236